Icon nabs molecular diagnostic lab to support precision medicine programs

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/JK1991)
(Image: Getty/JK1991)

Related tags: Icon, Diagnostics, Precision medicine

Icon acquired the molecular diagnostic laboratory MolecularMD to further support precision medicine programs across all development phases.

Dr. Steve Cutler, Icon CEO said on the company’s recent earrings call that acquisition enhances its laboratory offering in molecular diagnostic tests, “a key area in oncology research.”

The acquisition – terms of which were not disclosed – also expands Icon’s testing platforms with next-generation sequencing and immunohistochemistry. MolecularMD also provides companion diagnostics development services.

“[The acquisition is] not just the enhancement of our lab capabilities. I believe it's an enhancement of our clinical operations and our clinical program management capabilities as well,”​ Cutler added on the call.

An evaluation of the business will be conducted over the next couple of quarters, he noted.

“There are certainly some parts of the business that we look at and we think could be very, very nicely applied and synergized across our businesses. And I talked about that CAR-T and cell-based project expertise in the first-mover advantage we believe we have in that space and how that could be applied,”​ said Cutler.

Icon currently operates a network of fully accredited laboratory facilities, including central laboratories in Dublin, Ireland, Farmingdale NY, Singapore and Tianjin, China, as well as a bioanalytical laboratory in Whitesboro, NY.

The company also earlier this year launched a new drug safety reporting platform​.

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars